Abbott Laboratories (abt)
ABT Earnings
Public earnings and growth snapshot for Abbott Laboratories. Full earnings calendars, surprises, and multi-year history are available in Vest Terminal.
| Earnings growth (YoY) | -47.5% |
| Revenue growth (YoY) | 13.0% |
| Trailing P/E | 33.60 |
| Forward P/E | 17.06 |
| Last price | $103.49 |
| Market cap | $179.08B |
Start Free — open ABT in Vest Terminal
Access live data, filings, ownership, and analysis for Abbott Laboratories.
Abbott Laboratories FAQ
What does Abbott Laboratories (ABT) do?
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers…
What is ABT's P/E ratio?
Abbott Laboratories has a trailing P/E of 33.60× based on publicly available market data.
Does ABT pay a dividend?
Indicated dividend yield: 2.4%. Confirm ex-dates and payout history in Vest Terminal.
What sector is ABT in?
Abbott Laboratories is classified in Healthcare (Medical Devices) on NYQ.
What is ABT's market capitalization?
Approximate market cap: $179.08B.
What are the main risks for ABT?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of ABT?
Potential positives include revenue growth of 13.0% year-over-year, gross margin of 56.8% supports competitive unit economics.
Where can I get analyst estimates for ABT?
Public analyst price targets and consensus for Abbott Laboratories are on the free /stocks/abt/estimates page. Deeper estimate history and models are available in Vest Terminal.